Cargando…

Intermolecular Mechanism and Dynamic Investigation of Avian Influenza H7N9 Virus’ Susceptibility to E119V-Substituted Peramivir–Neuraminidase Complex

The H7N9 virus attaches itself to the human cell receptor protein containing the polysaccharide that terminates with sialic acid. The mutation of neuraminidase at residue E119 has been explored experimentally. However, there is no adequate information on the substitution with E119V in peramivir at t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mtambo, Sphamandla E., Ugbaja, Samuel C., Mushebenge, Aganze G., Abubakar, Bahijjahtu H., Ntuli, Mthobisi L., Kumalo, Hezekiel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911867/ https://www.ncbi.nlm.nih.gov/pubmed/35268741 http://dx.doi.org/10.3390/molecules27051640

Ejemplares similares

Structural Investigations and Binding Mechanisms of Oseltamivir Drug Resistance Conferred by the E119V Mutation in Influenza H7N9 Virus
por: Ugbaja, Samuel C., et al.
Publicado: (2022)

Impact of the R292K Mutation on Influenza A (H7N9) Virus Resistance towards Peramivir: A Molecular Dynamics Perspective
por: Mtambo, Sphamandla E., et al.
Publicado: (2022)

Allostery Inhibition of BACE1 by Psychotic and Meroterpenoid Drugs in Alzheimer’s Disease Therapy
por: Ugbaja, Samuel C., et al.
Publicado: (2022)

Unveiling the Inhibitory Potentials of Peptidomimetic Azanitriles and Pyridyl Esters towards SARS-CoV-2 Main Protease: A Molecular Modelling Investigation
por: Mushebenge, Aganze G., et al.
Publicado: (2023)

In Silico Drug Repurposing of FDA-Approved Drugs Highlighting Promacta as a Potential Inhibitor of H7N9 Influenza Virus
por: Mtambo, Sphamandla E., et al.
Publicado: (2022)

Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors
por: Mushebenge, Aganze Gloire-Aimé, et al.
Publicado: (2023)

Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor Design
por: Mtambo, Sphamadla E., et al.
Publicado: (2021)

Clinical Effectiveness of Peramivir in Comparison with Other Neuraminidase Inhibitors in Pediatric Influenza Patients
por: Hikita, Toshiyuki, et al.
Publicado: (2012)

Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections
por: Alame, Malak M., et al.
Publicado: (2016)

A Meta-Analysis Comparing the Efficacy and Safety of Peramivir with Other Neuraminidase Inhibitors for Influenza Treatment
por: Chen, Jui-Yi, et al.
Publicado: (2020)

Peramivir for influenza
Publicado: (2019)

Independent-Trajectories Thermodynamic-Integration Free-Energy Changes for Biomolecular Systems: Determinants of H5N1 Avian Influenza Virus Neuraminidase Inhibition by Peramivir
por: Lawrenz, Morgan, et al.
Publicado: (2009)

Evaluation of Baloxavir Marboxil and Peramivir for the Treatment of High Pathogenicity Avian Influenza in Chickens
por: Twabela, Augustin, et al.
Publicado: (2020)

Peramivir and laninamivir susceptibility of circulating influenza A and B viruses
por: Leang, Sook-Kwan, et al.
Publicado: (2014)

Heat Shock Protein 90 (HSP90) Inhibitors as Anticancer Medicines: A Review on the Computer-Aided Drug Discovery Approaches over the Past Five Years
por: Magwenyane, Ayanda M., et al.
Publicado: (2022)

Substitution of I222L-E119V in neuraminidase from highly pathogenic avian influenza H7N9 virus exhibited synergistic resistance effect to oseltamivir in mice
por: Tang, Jing, et al.
Publicado: (2021)

Mapping evidence of the concomitant management of schistosomiasis by traditional health practitioners and health care professionals in communities with high prevalent infections: a systematic scoping review protocol
por: Mushebenge, Gloire-Aimé Aganze, et al.
Publicado: (2019)

Cause of hospitalization and death in the antiretroviral era in Sub-Saharan Africa published 2008–2018: A systematic review
por: Ghislain, Manimani Riziki, et al.
Publicado: (2021)

Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K
por: Tran-To Su, Chinh, et al.
Publicado: (2013)

Safety and efficacy of peramivir for influenza treatment
por: Hata, Atsuko, et al.
Publicado: (2014)

Competitive Fitness of Influenza B Viruses Possessing E119A and H274Y Neuraminidase Inhibitor Resistance–Associated Substitutions in Ferrets
por: Pascua, Philippe Noriel Q., et al.
Publicado: (2016)

Oseltamivir/peramivir: Lack of efficacy: case report
Publicado: (2020)

Evidence on collaboration of traditional and biomedical practitioners in the management of antimicrobial resistance in sub-Saharan Africa over 15 years: a systematic review protocol
por: Mushebenge, Aganze Gloire-Aimé, et al.
Publicado: (2021)

Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model
por: Farooqui, Amber, et al.
Publicado: (2015)

Transetherification on Polyols by Intra- and Intermolecular Nucleophilic Substitutions
por: Muraoka, Takahiro, et al.
Publicado: (2014)

Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: a case report
por: Harada, Naonori, et al.
Publicado: (2020)

Theory and Applications of Covalent Docking in Drug Discovery: Merits and Pitfalls
por: Kumalo, Hezekiel Mathambo, et al.
Publicado: (2015)

Mechanism of Inhibition of Hsp90 Dimerization by Gyrase B Inhibitor Coumermycin A1 (C–A1) Revealed by Molecular Dynamics Simulations and Thermodynamic Calculations
por: Cele, Favourite N., et al.
Publicado: (2016)

Evolutionary interactions between haemagglutinin and neuraminidase in avian influenza
por: Ward, Melissa J, et al.
Publicado: (2013)

Peramivir injection in the treatment of acute influenza: a review of the literature
por: Wester, Ashley, et al.
Publicado: (2016)

PEPT1-mediated prodrug strategy for oral delivery of peramivir
por: Sun, Yongbing, et al.
Publicado: (2018)

$^{119}$Sn Mössbauer study of the implantation behaviour of $^{119}$In, $^{119}$Sn, $^{119m}$Sn, $^{119}$Sb and $^{119m}$Te ions in SiC
por: Petersen, J W, et al.
Publicado: (1985)

Single Dose IV Peramivir is Safe and Effective in the Treatment of Pediatric Influenza
por: Vanchiere, John, et al.
Publicado: (2017)

Amino acid substitutions in the neuraminidase protein of an H9N2 avian influenza virus affect its airborne transmission in chickens
por: Lv, Jing, et al.
Publicado: (2015)

Surveillance of antiviral resistance markers in Argentina: detection of E119V neuraminidase mutation in a post-treatment immunocompromised patient
por: Pontoriero, Andrea, et al.
Publicado: (2016)

The decay of $]^{119}$Cd and $\^{119}$In isomers
por: Scheidemann, O, et al.
Publicado: (1976)

Intermolecular interactions in a phenol-substituted benzimidazole
por: Geiger, David K., et al.
Publicado: (2019)

Emergence and Genetic Variation of Neuraminidase Stalk Deletions in Avian Influenza Viruses
por: Li, Jinling, et al.
Publicado: (2011)

Secondary metabolites produced by endophytic fungi, Alternaria alternata, as potential inhibitors of the human immunodeficiency virus
por: Nzimande, Bruce, et al.
Publicado: (2022)

A Case of Influenza Associated Fulminant Myocarditis Successfully Treated with Intravenous Peramivir
por: Baik, Seung Hee, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fe5036e5592levegjirv3dhuia